amitriptyline has been researched along with Lesion of Sciatic Nerve in 8 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
" Whereas acute treatments were ineffective, chronic administration of amitriptyline reduced CCI-SN-induced hyperalgesia-like behavior, and this effect was markedly enhanced by co-administration of mefloquine, which was inactive on its own." | 1.43 | Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats. ( Bourgoin, S; Charvériat, M; Duchêne, A; Ezan, P; Giaume, C; Hamon, M; Jeanson, T; Mouthon, F; Picoli, C; Richard, D, 2016) |
"Similar bilateral hyperalgesia was observed when axotomy was performed using silk thread instead of chromic gut." | 1.33 | Effects of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axotomy. ( Miki, S; Senba, E; Yasuda, T; Yoshinaga, N, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeanson, T | 1 |
Duchêne, A | 1 |
Richard, D | 1 |
Bourgoin, S | 1 |
Picoli, C | 1 |
Ezan, P | 1 |
Mouthon, F | 1 |
Giaume, C | 1 |
Hamon, M | 1 |
Charvériat, M | 1 |
Song, L | 2 |
Yang, B | 2 |
Kang, X | 2 |
Xiao, H | 2 |
Yang, F | 2 |
Liu, H | 2 |
Wen, C | 1 |
Song, Z | 1 |
Meyerson, BA | 1 |
Linderoth, B | 1 |
Yasuda, T | 1 |
Miki, S | 1 |
Yoshinaga, N | 1 |
Senba, E | 1 |
Walker, M | 1 |
Meekins, G | 1 |
Hu, SC | 1 |
O'Ferrall, EK | 1 |
Busche, K | 1 |
Dickhoff, P | 1 |
Zabad, R | 1 |
Toth, C | 1 |
Benbouzid, M | 1 |
Choucair-Jaafar, N | 1 |
Yalcin, I | 1 |
Waltisperger, E | 1 |
Muller, A | 1 |
Freund-Mercier, MJ | 1 |
Barrot, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Single Blinded, Randomized Control Trial of High Frequency Stimulation in Subjects With Precision® Spinal Cord Stimulator System to Assess Efficacy and Preferability in Back and Extremity Pain Relief[NCT02265848] | Phase 4 | 22 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Digital pain rating system that scores patient's subjective pain rating from 0 to 10; with greater number indicating progressively worsening pain. NPRS were measured at baseline (visit1), and at each follow ups visits at visit 2, 3 and 4. Visit 2 and 4 captured post treatment (either 1000 Hz or standard stimulation depending on the randomization) results, and visit 3 captured NPRS after the wash off from the spinal cord stimulation. (NCT02265848)
Timeframe: Baseline (visit 1), and at each follow up visits (visits 2, 3, and 4)
Intervention | units on a scale (Mean) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Average Baseline NPRS Score | Average NPRS after 1000 Hz. stimulation | Average NPRS after standard stimulation | Average NPRS after Wash off | Best Baseline NPRS score | Best NPRS score after 1000 Hz. stimulation | Best NPRS score after standard stimulation | Best NPRS after Wash off | Worst Baseline NPRS score | Worst NPRS score after 1000 Hz. stimulation | Worst NPRS score after standard stimulation | Worst NPRS after Wash off | |
Treatment Group A | 6.09 | 3.73 | 5.64 | 6.45 | 3.72 | 2.64 | 3.46 | 4.54 | 7.90 | 6.64 | 8.18 | 8.72 |
Treatment Group B | 6.27 | 3.82 | 6.09 | 7.18 | 4.45 | 2.18 | 4.45 | 5.36 | 8.09 | 6.64 | 8.36 | 8.81 |
ODI is a outcome metrics that is design to assess the severity of disability based on 10 activity categories. ODI is based on 0 to 100% scale, where larger percentage implies worse disability. (There are 5 categories: 0-20%: Minimal disability, 21-40%: Moderate disability, 41-60%: Severe disability, 61-80%: Crippled. 81-100%: Either bed bound or exaggerating symptoms). ODI were measured at baseline (visit1), and at each follow ups visits at visit 2, 3 and 4. Visit 2 and 4 captured post treatment (either 1000 Hz or standard stimulation depending on the randomization) results, and visit 3 captured NPRS after the wash off from the spinal cord stimulation. (NCT02265848)
Timeframe: Baseline (visit 1), and at each follow up visits (visits 2, 3, and 4)
Intervention | units on a scale (Mean) | |||
---|---|---|---|---|
Baseline ODI score | ODI after 1000 Hz. stimluation | ODI after standard stimulation | ODI after wash off | |
Treatment Group A | 47.49 | 39.23 | 49.63 | 52.87 |
Treatment Group B | 51.25 | 33.77 | 49.05 | 56.77 |
PGIC is a 7-point scale that requires study subjects to rate the severity of their illness or medical condition after a specific treatment. 1: No change, 2: Almost the same, 3: A little better, 4: Somewhat better, 5: Moderately better, 6: Better, 7: A great deal better. Study subjects were asked to report their impression of changes at baseline visit, visit 2 through 4. (NCT02265848)
Timeframe: Baseline (visit 1), and at each follow up visits (visits 2, 3, and 4)
Intervention | units on a scale (Mean) | ||
---|---|---|---|
PGIC After 1000 Hz. stimulation | PGIC after standard stimulation | PGIC after Wash off | |
Treatment Group A | 4.27 | 2.54 | 1.45 |
Treatment Group B | 5.91 | 2.45 | 1.27 |
At the conclusion of the study, subjects were asked to report which spinal cord stimulation modes they preferred. Subjects were presented with two boxes (1000 Hz. stimulation and Standard stimulation) and asked to check one. (NCT02265848)
Timeframe: End of treatment visit on visit 4
Intervention | participants (Number) | |
---|---|---|
Subjects who prefer 1000 Hz. stimulation | Subjects who prefer standard stimulation | |
Treatment Group A | 8 | 3 |
Treatment Group B | 10 | 1 |
8 other studies available for amitriptyline and Lesion of Sciatic Nerve
Article | Year |
---|---|
Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats.
Topics: Amitriptyline; Animals; Astrocytes; Connexin 43; Gap Junctions; Hyperalgesia; Male; Neuralgia; Rats; | 2016 |
[Peripheral anti-hyperalgesic effect of amitriptyline for sciatic nerve blockade on neuropathic pain of rats].
Topics: Amitriptyline; Animals; Disease Models, Animal; Male; Pain Threshold; Rats; Rats, Sprague-Dawley; Sc | 2008 |
[Peripheral anti-hyperalgesic effect and neurotoxicologic screening of amitriptyline and bupivacaine on sciatic nerve blockade chronically on neuropathic pain in rats].
Topics: Amitriptyline; Animals; Bupivacaine; Male; Nerve Block; Pain Measurement; Rats; Rats, Sprague-Dawley | 2009 |
The interaction between antidepressant drugs and the pain-relieving effect of spinal cord stimulation in a rat model of neuropathy.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; C | 2011 |
Effects of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axotomy.
Topics: Amines; Amitriptyline; Animals; Anticonvulsants; Antidepressive Agents; Axotomy; Cyclohexanecarboxyl | 2005 |
Yoga neuropathy. A snoozer.
Topics: Adult; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Disorders of Excessive S | 2005 |
A patient with bilateral sciatic neuropathies.
Topics: Adult; Amitriptyline; Antidepressive Agents; Buttocks; Compartment Syndromes; Drug Overdose; Female; | 2007 |
Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.
Topics: Amines; Amitriptyline; Animals; Anticonvulsants; Antidepressive Agents, Tricyclic; Brain; Chronic Di | 2008 |